Alcon
Search results
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience and expertise, Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
- Products & Services
Bachem offers more than 5000 different biologically active...
- About Bachem
Bachem is a leading, innovation-driven company specializing...
- News & Events
As Bachem is the world’s leading company in developing and...
- Knowledge Center
Bachem provides a wide range of documentation and practical...
- Careers
Bachem is committed to working with and providing reasonable...
- Contact
Bachem AG Hauptstrasse 144 4416 Bubendorf Switzerland. Tel...
- CMC Development
Certainly, Bachem's expertise in peptides, their...
- Commercial API
You come first – We pride ourselves on a consistently high...
- Products & Services
Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals. It specializes in the commercial production of peptides and complex organic compounds as active pharmaceutical ingredients , in the production of peptide-based biochemicals and in the development of manufacturing processes for these compounds.
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem Holding AG is a Swiss bio-technology company active in the fields of chemistry, biochemistry and pharmaceuticals. It specializes in the commercial production of peptides and complex organic ...
vision & strategy. Learn about the key values of Bachem: customer centricity and service, innovation and technology, operational excellence and quality, people and culture, and sustainability.
4 BACHEM ANNUAL REPORT 2023 Bachem has thus delivered a good annual result. The Board of Directors will propose to the Annual General Meeting that the dividend be increased by CHF 0.05 to CHF 0.80 per share. As a specialist in peptides and oligonucleotides, Bachem is a leading supplier of complex molecules. In this space,
People also ask
Who is Bachem Holding AG?
What does Bachem do?
Is Bachem a good company?
Does Bachem Holding AG have a capital band or Condit?
Jul 18, 2024 · Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes.
